We are live on ! Find out more

SS Innovations International

SSII

Market cap $333M

1.66 USD

+0.34

25.76%

At close Updated Nov 13, 4:00 PM EST

Pre-market

After hours

1.65

-0.01

0.6%

1 day

25.76%

5 days

-20.95%

1 month

-34.9%

3 months

-56.66%

6 months

-58.4%

Year to date

-70.62%

1 year

-74.1%

5 years

-85.37%

10 years

-85.37%

About: SS Innovations International Inc is a commercial-stage surgical robotics company. It designs, manufactures, and markets a surgical robotic system called the SSi Mantra Surgical Robotic System (the SSi Mantra) intended for use in urology, general, gynecology, colorectal, gastroenterology, head and neck, thoracic, and cardiac surgeries. Additionally, the company offers a suite of stapling, energy, and core instrumentation for its surgical systems, under the brand name of SSi Mudra.

Employees: 483

Healthcare Medical Devices

News

Positive

Neutral

Negative

Sentiment 3-Months

Positive 14.3%

Neutral 71.4%

Negative 14.3%

SS Innovations Strengthens Management Team in Preparation for Global Sales Expansion

Promotes Dr. Vishwa Srivastava to President and Appoints Gary Lo as Chief Financial Officer FORT LAUDERDALE, Fla., Nov. 13, 2026 (GLOBE NEWSWIRE) -- via IBN -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (NASDAQ: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced the promotion of Dr. Vishwa Srivastava to President of the Company and the appointment of Gary Lo as Chief Financial Officer.

SS Innovations Strengthens Management Team in Preparation for Global Sales Expansion

SS Innovations Showcases SSi Mantra Telesurgery Capabilities at October 2026 Conferences

FORT LAUDERDALE, Fla., Oct. 26, 2026 (GLOBE NEWSWIRE) -- via IBN – SS Innovations International, Inc. (the “Company” or “SS Innovations”) (NASDAQ: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced that the Company's SSi Mantra surgical robotic system (the “SSi Mantra”) and SSi MantrAsana tele-surgeon console (the “SSi MantrAsana”) were showcased in successful telesurgeries performed in October 2026 during the European Association for Cardio-Thoracic Surgery (“EACTS”) Annual Meeting in Barcelona, Spain and the Society of Robotic Surgery India (“SRS India”) Conference in New Delhi, India.

SS Innovations Showcases SSi Mantra Telesurgery Capabilities at October 2026 Conferences

Zacks Investment Research

SSi Falls 32% in Three Months: Should You Buy the Dip or Wait?

SSII's rising revenues and robotic surgery adoption signal growth, but widening losses and financing pressures pose challenges to profitability.

SSi Falls 32% in Three Months: Should You Buy the Dip or Wait?

SS Innovations Submits Response to FDA Request for Additional Information Regarding the Company's 510(k) Submission for the SSi Mantra

FORT LAUDERDALE, Fla., Oct. 13, 2026 (GLOBE NEWSWIRE) -- via IBN -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (NASDAQ: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced that, on October 5, 2026, the Company submitted its response to a request for additional information letter (the “AINN”) received from the United States Food and Drug Administration (the “FDA”) with regard to the Company's 510(k) submission for its SSi Mantra surgical robotic system (the “SSi Mantra”).

SS Innovations Submits Response to FDA Request for Additional Information Regarding the Company's 510(k) Submission for the SSi Mantra

Zacks Investment Research

2 International Microcaps for Your Watchlist

SSII and IVDA have sales predominantly in India and Taiwan, respectively.

2 International Microcaps for Your Watchlist

Zacks Investment Research

Zacks Initiates Coverage of SSi With Neutral Recommendation

Discover why Zacks initiated coverage of SSII with a "Neutral" rating, being the first on Wall Street to initiate coverage on the stock. Explore how expanding robotic surgery adoption, rising revenues and international growth are offset by persistent losses and regulatory hurdles.

Zacks Initiates Coverage of SSi With Neutral Recommendation

SS Innovations Provides Update on Continuing Progress and Milestones

-- Advancing global expansion, pediatric robotic surgery and telesurgery -- -- Growing SSi Mantra installations, procedures and utilization -- FORT LAUDERDALE, Fla., Sept. 10, 2026 (GLOBE NEWSWIRE) -- via IBN -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (NASDAQ: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today provided an update on the Company's continuing progress and milestones.

SS Innovations Provides Update on Continuing Progress and Milestones

SS Innovations Reports Second Quarter 2026 Financial Results

Record quarterly revenue driven by continuing strong growth in SSi Mantra unit sales Record quarterly revenue driven by continuing strong growth in SSi Mantra unit sales

SS Innovations Reports Second Quarter 2026 Financial Results

SS Innovations To Showcase the SSi Mantra Surgical Robotic System at SRS 2026

Company's advanced surgical robotic system will be on display, spotlighted in multiple breakout sessions, and featured in a kidney telesurgery to be broadcast live at the premier industry event Company's advanced surgical robotic system will be on display, spotlighted in multiple breakout sessions, and featured in a kidney telesurgery to be broadcast live at the premier industry event

SS Innovations To Showcase the SSi Mantra Surgical Robotic System at SRS 2026

SS Innovations Appoints Sarah M. Romano as Chief Financial Officer

Veteran medtech finance executive brings extensive public company and capital markets experience to support the Company's next phase of global growth Veteran medtech finance executive brings extensive public company and capital markets experience to support the Company's next phase of global growth

SS Innovations Appoints Sarah M. Romano as Chief Financial Officer

See News Rankings

Price charts implemented using Lightweight Charts™